Page 11234

Category Archives: Cardiovascular Pharmacology

Latest Research Report to uncover key Factors of Global Cardiovascular Repair And Reconstruction Devices Market – Market Research Base

Posted: November 6, 2019 at 8:45 pm

Cardiovascular repair and reconstruction devices are segmented into heart valve repair, cardiovascular grafts and cardiovascular patches. There is an increase in demand for cardiovascular repair and reconstruction devices market due to the increase in prevalence of Congenital Heart Defects and technological advancements in molecular chemistry, clinical pharmacology, cell biology and vascular surgery. Access Report Details at: https://www.themarketreports.com/report/global-cardiovascular-repair-and-reconstruction-devices-market-research-report The global Cardiovascular Repair And Reconstruction Devices market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025 Continue reading

Posted in Cardiovascular Pharmacology | Comments Off on Latest Research Report to uncover key Factors of Global Cardiovascular Repair And Reconstruction Devices Market – Market Research Base

Edited Transcript of CYTK earnings conference call or presentation 31-Oct-19 8:30pm GMT – Yahoo Finance

Posted: at 8:45 pm

South San Francisco Nov 6, 2019 (Thomson StreetEvents) -- Edited Transcript of Cytokinetics Inc earnings conference call or presentation Thursday, October 31, 2019 at 8:30:00pm GMT * Ching W. Jaw * Robert I. Blum H.C. Continue reading

Posted in Cardiovascular Pharmacology | Comments Off on Edited Transcript of CYTK earnings conference call or presentation 31-Oct-19 8:30pm GMT – Yahoo Finance

The Montreal Heart Institute celebrates its 500th heart transplant – GlobeNewswire

Posted: at 8:45 pm

First heart transplant in Canada was performed at the Montreal Heart Institute First heart transplant in Canada was performed at the Montreal Heart Institute Fondation de lInstitut de Cardiologie de Montral MONTREAL, Quebec, Oct. 31, 2019 (GLOBE NEWSWIRE) -- The Montreal Heart Institute is proud to announce that the milestone of 500 heart transplants has been successfully completed recently. Continue reading

Posted in Cardiovascular Pharmacology | Comments Off on The Montreal Heart Institute celebrates its 500th heart transplant – GlobeNewswire

Potential PF Therapy AD-214 to Move into Phase 1 Testing in Humans – Pulmonary Fibrosis News

Posted: at 8:45 pm

Investigational therapy AD-214 raised no safety concerns in preliminary studies in non-human primates, and AdAlta, the therapys developer, is now planning to launch a Phase 1 clinical trial in humans, the company announced. AD-214 is amodification of AdAltas original lead candidate for the treatment of pulmonary fibrosis (PF), AD-114. AD-214 contains two i-bodies modified antibodies that specifically target the protein CXCR4 Continue reading

Posted in Cardiovascular Pharmacology | Comments Off on Potential PF Therapy AD-214 to Move into Phase 1 Testing in Humans – Pulmonary Fibrosis News

The 9 Biggest Technology Trends That Will Transform Medicine And Healthcare In 2020 – Forbes

Posted: at 8:45 pm

Healthcare is an industry that is currently being transformed using the latest technology, so it can meet the challenges it is facing in the 21st century. Technology can help healthcare organizations meet growing demand and efficiently operate to deliver better patient care. Here are 9 technology trends that will transform medicine and healthcare in 2020 Continue reading

Posted in Cardiovascular Pharmacology | Comments Off on The 9 Biggest Technology Trends That Will Transform Medicine And Healthcare In 2020 – Forbes

Advanced Drug Delivery Systems Market Growth Analysis 2019 to Share Key Aspects of the Industry with the details of Influence Factors Forecast to 2024…

Posted: October 28, 2019 at 9:43 am

The Advanced Drug Delivery Systems Market research report 2019-2024 focuses on the major drivers, restraints, opportunities and threats for key players. It also provides granular analysis of market share, segmentation, revenue forecasts and regional analysis till 2024. Continue reading

Posted in Cardiovascular Pharmacology | Comments Off on Advanced Drug Delivery Systems Market Growth Analysis 2019 to Share Key Aspects of the Industry with the details of Influence Factors Forecast to 2024…

Best supplements for blood pressure: The natural remedy proven to lower your reading – Express

Posted: October 7, 2019 at 6:43 pm

High blood pressure is often branded the silent killer because it tends to creep up announced and only reveal itself when it is serious. The condition can raise a persons risk of developing deadly cardiovascular complications. Continue reading

Posted in Cardiovascular Pharmacology | Comments Off on Best supplements for blood pressure: The natural remedy proven to lower your reading – Express

G-Protein Coupled Receptors (GPCRs) Market Size And Prediction By Leading Manufacturers According To Its Application And Types Till 2022 – Space…

Posted: at 6:43 pm

GPCRs market comprises assays and kits that aid in drug discovery and development. GPCRs is a large family of cell surface receptors that respond to a diverse range of external stimulus and play a major role in modern pharmacology due to their significant function in cell communication. More than 30% of the drugs available in the global market target GPCRs and most of the drugs that are currently under clinical and preclinical studies target this highly studied receptor protein Continue reading

Posted in Cardiovascular Pharmacology | Comments Off on G-Protein Coupled Receptors (GPCRs) Market Size And Prediction By Leading Manufacturers According To Its Application And Types Till 2022 – Space…

Verve Therapeutics Appoints Cardiologist Andrew Bellinger, M.D., Ph.D., as Chief Scientific Officer – Business Wire

Posted: at 6:43 pm

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verve Therapeutics, a next-generation cardiovascular company developing therapies that safely edit the adult human genome to permanently reduce a persons risk of coronary artery disease, today announced the appointment of physician and scientist Andrew Bellinger, M.D., Ph.D., as the companys chief scientific officer. Dr Continue reading

Posted in Cardiovascular Pharmacology | Comments Off on Verve Therapeutics Appoints Cardiologist Andrew Bellinger, M.D., Ph.D., as Chief Scientific Officer – Business Wire

Yale alumna Dr. Nancy Brown named dean of Yale School of Medicine – Yale News

Posted: September 18, 2019 at 4:35 pm

Dr. Continue reading

Posted in Cardiovascular Pharmacology | Comments Off on Yale alumna Dr. Nancy Brown named dean of Yale School of Medicine – Yale News

Page 11234